GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Pretax Margin %

Oncodesign Precision Medicine (XPAR:ALOPM) Pretax Margin % : -1,567.89% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Oncodesign Precision Medicine's Pre-Tax Income for the six months ended in Dec. 2023 was €-5.13 Mil. Oncodesign Precision Medicine's Revenue for the six months ended in Dec. 2023 was €0.33 Mil. Therefore, Oncodesign Precision Medicine's pretax margin for the quarter that ended in Dec. 2023 was -1,567.89%.

The historical rank and industry rank for Oncodesign Precision Medicine's Pretax Margin % or its related term are showing as below:

XPAR:ALOPM' s Pretax Margin % Range Over the Past 10 Years
Min: -2160.89   Med: -124.08   Max: -21.59
Current: -2160.89


XPAR:ALOPM's Pretax Margin % is ranked worse than
81.97% of 1004 companies
in the Biotechnology industry
Industry Median: -146.86 vs XPAR:ALOPM: -2160.89

Oncodesign Precision Medicine Pretax Margin % Historical Data

The historical data trend for Oncodesign Precision Medicine's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Pretax Margin % Chart

Oncodesign Precision Medicine Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Pretax Margin %
-141.68 -106.47 -21.59 -919.59

Oncodesign Precision Medicine Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Pretax Margin % Get a 7-Day Free Trial -890.21 28.97 -635.03 -1,567.89 -4,100.00

Competitive Comparison of Oncodesign Precision Medicine's Pretax Margin %

For the Biotechnology subindustry, Oncodesign Precision Medicine's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncodesign Precision Medicine's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncodesign Precision Medicine's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Oncodesign Precision Medicine's Pretax Margin % falls into.



Oncodesign Precision Medicine Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Oncodesign Precision Medicine's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-9.858/1.072
=-919.59 %

Oncodesign Precision Medicine's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-5.127/0.327
=-1,567.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oncodesign Precision Medicine  (XPAR:ALOPM) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Oncodesign Precision Medicine Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncodesign Precision Medicine Business Description

Traded in Other Exchanges
Address
18 rue Jean Mazen, Dijon, FRA, 21000
Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine Headlines

No Headlines